Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial - PubMed (original) (raw)
Randomized Controlled Trial
Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial
Steven A Safren et al. JAMA. 2010.
Abstract
Context: Attention-deficit/hyperactivity disorder (ADHD) in adulthood is a prevalent, distressing, and impairing condition that is not fully treated by pharmacotherapy alone and lacks evidence-based psychosocial treatments.
Objective: To test cognitive behavioral therapy for ADHD in adults treated with medication but who still have clinically significant symptoms.
Design, setting, and patients: Randomized controlled trial assessing the efficacy of cognitive behavioral therapy for 86 symptomatic adults with ADHD who were already being treated with medication. The study was conducted at a US hospital between November 2004 and June 2008 (follow-up was conducted through July 2009). Of the 86 patients randomized, 79 completed treatment and 70 completed the follow-up assessments.
Interventions: Patients were randomized to 12 individual sessions of either cognitive behavioral therapy or relaxation with educational support (which is an attention-matched comparison).
Main outcome measures: The primary measures were ADHD symptoms rated by an assessor (ADHD rating scale and Clinical Global Impression scale) at baseline, posttreatment, and at 6- and 12-month follow-up. The assessor was blinded to treatment condition assignment. The secondary outcome measure was self-report of ADHD symptoms.
Results: Cognitive behavioral therapy achieved lower posttreatment scores on both the Clinical Global Impression scale (magnitude -0.0531; 95% confidence interval [CI], -1.01 to -0.05; P = .03) and the ADHD rating scale (magnitude -4.631; 95% CI, -8.30 to -0.963; P = .02) compared with relaxation with educational support. Throughout treatment, self-reported symptoms were also significantly more improved for cognitive behavioral therapy (beta = -0.41; 95% CI, -0.64 to -0.17; P <001), and there were more treatment responders in cognitive behavioral therapy for both the Clinical Global Impression scale (53% vs 23%; odds ratio [OR], 3.80; 95% CI, 1.50 to 9.59; P = .01) and the ADHD rating scale (67% vs 33%; OR, 4.29; 95% CI, 1.74 to 10.58; P = .002). Responders and partial responders in the cognitive behavioral therapy condition maintained their gains over 6 and 12 months.
Conclusion: Among adults with persistent ADHD symptoms treated with medication, the use of cognitive behavioral therapy compared with relaxation with educational support resulted in improved ADHD symptoms, which were maintained at 12 months.
Trial registration: clinicaltrials.gov Identifier: NCT00118911.
Figures
Figure 1
Flow of Patients From Randomization Through Analysis ADHD indicates attention-deficit/hyperactivity disorder; CGI, Clinical Global Impression scale.
Figure 2
Mixed-Effects Analysis of Self-report Current Symptoms Scale Score for Baseline to Posttreatment CBT indicates cognitive behavioral therapy. On the x-axis, the 0 time point indicates baseline and 13 weeks indicates posttreatment.
Comment in
- CBT is effective in reducing symptoms in adults with ADHD whose symptoms persist following pharmacotherapy.
Ramsay JR. Ramsay JR. Evid Based Ment Health. 2011 Feb;14(1):28. doi: 10.1136/ebmh.14.1.28. Evid Based Ment Health. 2011. PMID: 21266625 No abstract available.
Similar articles
- Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms: Follow-up Analysis of the COMPAS Trial.
Lam AP, Matthies S, Graf E, Colla M, Jacob C, Sobanski E, Alm B, Rösler M, Retz W, Retz-Junginger P, Kis B, Abdel-Hamid M, Müller HHO, Lücke C, Huss M, Jans T, Berger M, Tebartz van Elst L, Philipsen A; Comparison of Methylphenidate and Psychotherapy in Adult ADHD Study (COMPAS) Consortium. Lam AP, et al. JAMA Netw Open. 2019 May 3;2(5):e194980. doi: 10.1001/jamanetworkopen.2019.4980. JAMA Netw Open. 2019. PMID: 31150084 Free PMC article. Clinical Trial. - A randomized controlled trial of cognitive behavioral therapy for ADHD in medication-treated adolescents.
Sprich SE, Safren SA, Finkelstein D, Remmert JE, Hammerness P. Sprich SE, et al. J Child Psychol Psychiatry. 2016 Nov;57(11):1218-1226. doi: 10.1111/jcpp.12549. Epub 2016 Mar 17. J Child Psychol Psychiatry. 2016. PMID: 26990084 Free PMC article. Clinical Trial. - Group therapy for adolescents with attention-deficit/hyperactivity disorder: a randomized controlled trial.
Vidal R, Castells J, Richarte V, Palomar G, García M, Nicolau R, Lazaro L, Casas M, Ramos-Quiroga JA. Vidal R, et al. J Am Acad Child Adolesc Psychiatry. 2015 Apr;54(4):275-82. doi: 10.1016/j.jaac.2014.12.016. Epub 2015 Jan 26. J Am Acad Child Adolesc Psychiatry. 2015. PMID: 25791144 Clinical Trial. - Cognitive-behavioral approaches to ADHD treatment in adulthood.
Safren SA. Safren SA. J Clin Psychiatry. 2006;67 Suppl 8:46-50. J Clin Psychiatry. 2006. PMID: 16961430 Review. - Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.
Verbeeck W, Bekkering GE, Van den Noortgate W, Kramers C. Verbeeck W, et al. Cochrane Database Syst Rev. 2017 Oct 2;10(10):CD009504. doi: 10.1002/14651858.CD009504.pub2. Cochrane Database Syst Rev. 2017. PMID: 28965364 Free PMC article. Review.
Cited by
- Cognitive behavior therapy for adults with attention-deficit/hyperactivity disorder: a review of recent randomized controlled trials.
Mongia M, Hechtman L. Mongia M, et al. Curr Psychiatry Rep. 2012 Oct;14(5):561-7. doi: 10.1007/s11920-012-0303-x. Curr Psychiatry Rep. 2012. PMID: 22878974 Review. - Investigating the efficacy of integrated cognitive behavioral therapy for adult treatment seeking substance use disorder patients with comorbid ADHD: study protocol of a randomized controlled trial.
van Emmerik-van Oortmerssen K, Vedel E, Koeter MW, de Bruijn K, Dekker JJ, van den Brink W, Schoevers RA. van Emmerik-van Oortmerssen K, et al. BMC Psychiatry. 2013 May 10;13:132. doi: 10.1186/1471-244X-13-132. BMC Psychiatry. 2013. PMID: 23663651 Free PMC article. Clinical Trial. - TMP19: A Novel Ternary Motif Pattern-Based ADHD Detection Model Using EEG Signals.
Barua PD, Dogan S, Baygin M, Tuncer T, Palmer EE, Ciaccio EJ, Acharya UR. Barua PD, et al. Diagnostics (Basel). 2022 Oct 20;12(10):2544. doi: 10.3390/diagnostics12102544. Diagnostics (Basel). 2022. PMID: 36292233 Free PMC article. - Parenting in adults with attention-deficit/hyperactivity disorder (ADHD).
Johnston C, Mash EJ, Miller N, Ninowski JE. Johnston C, et al. Clin Psychol Rev. 2012 Jun;32(4):215-28. doi: 10.1016/j.cpr.2012.01.007. Epub 2012 Feb 12. Clin Psychol Rev. 2012. PMID: 22459785 Free PMC article. Review. - Psychosocial Interventions for Attention Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis by the CADDRA Guidelines Work GROUP.
Tourjman V, Louis-Nascan G, Ahmed G, DuBow A, Côté H, Daly N, Daoud G, Espinet S, Flood J, Gagnier-Marandola E, Gignac M, Graziosi G, Mansuri Z, Sadek J. Tourjman V, et al. Brain Sci. 2022 Aug 1;12(8):1023. doi: 10.3390/brainsci12081023. Brain Sci. 2022. PMID: 36009086 Free PMC article. Review.
References
- American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th ed, text revision American Psychiatric Association; Washington, DC: 2000.
- Prince J, Wilens T, Spencer T, Biederman J. Pharmacotherapy of ADHD in adults. In: Barkley RA, editor. Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. 3rd ed Guilford; New York, NY: 2006. pp. 704–736.
- Steele M, Jensen PS, Quinn DMP. Remission versus response as the goal of therapy in ADHD: a new standard for the field? Clin Ther. 2006;28(11):1892–1908. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical